Kimberley A. Lentz
Bristol-Myers Squibb (United States)(US)
Publications by Year
Research Areas
Drug Transport and Resistance Mechanisms, Alzheimer's disease research and treatments, Computational Drug Discovery Methods, Drug Solubulity and Delivery Systems, Stress Responses and Cortisol
Most-Cited Works
- → Discovery and Evaluation of BMS-708163, a Potent, Selective and Orally Bioavailable γ-Secretase Inhibitor(2010)184 cited
- → Current Methods for Predicting Human Food Effect(2008)156 cited
- → Predicting Effect of Food on Extent of Drug Absorption Based on Physicochemical Properties(2007)154 cited
- → Influence of Passive Permeability on Apparent P-glycoprotein Kinetics(2000)126 cited
- → Increased Acyclovir Oral Bioavailability via a Bile Acid Conjugate(2003)120 cited
- → Inhibition of AAK1 Kinase as a Novel Therapeutic Approach to Treat Neuropathic Pain(2016)119 cited
- → Aqueous and cosolvent solubility data for drug-like organic compounds(2005)114 cited
- → Development of a more rapid, reduced serum culture system for Caco-2 monolayers and application to the biopharmaceutics classification system(2000)91 cited
- → Discovery of (5S,6S,9R)-5-Amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl 4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxylate (BMS-927711): An Oral Calcitonin Gene-Related Peptide (CGRP) Antagonist in Clinical Trials for Treating Migraine(2012)86 cited
- → Development and Validation of a Preclinical Food Effect Model(2006)85 cited